Orthovita Shareholders Sue Over $316M Stryker Deal
The shareholders accuse Orthovita's board of directors of breaching their fiduciary duties by approving an inadequate consideration that was "the result of a flawed process tainted with conflicts."
The allegations echo those filed May 27 in Pennsylvania state court by another putative class of shareholders. Both groups have requested injunctions that would stop the proposed...
To view the full article, register now.